Outlook Therapeutics Reports New Positive 12-Month Safety Data from Pivotal Phase 3 NORSE TWO Trial
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with prior published data on ophthalmic...
Full year data reinforce strong safety profile consistent with previous trials of ONS-5010 and with prior published data on ophthalmic...
Study to focus on women of African American descent for expanded polygenic risk testMELBOURNE, Australia, Sept. 28, 2021 (GLOBE NEWSWIRE)...
Snow Family Dentistry (+1-480-982-7289) updated its Invisalign clear aligner orthodontic treatments for patients in Mesa, Arizona with underbite, overbite, crossbite,...
- Small Business Innovation Research (SBIR) contract to support development of pipeline program SENTI-202, a Logic Gated allogeneic CAR-NK cell...
Partnership to focus on empowering women to take ownership of their health and healthcare optionsPRINCETON, N.J., Sept. 28, 2021 (GLOBE...
Unique FAP targeting warhead combined with Actinium-225 or Lutetium-177 demonstrated complete tumor regression and long-term survival in preclinical models Initiation...
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 28, 2021 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on...
ORANGE, Calif., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Medicare Advantage company Alignment Healthcare (NASDAQ: ALHC) today announced the addition of...
Conference Call and Webcast Scheduled for October 12, 2021, 8:30 am ET NEW YORK, NY, Sept. 28, 2021 (GLOBE NEWSWIRE)...
DUBLIN, Ireland and CHICAGO, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical...
-- ENA Respiratory engages PPD, Inc. for Phase 2 COVID-19 post-exposure prophylaxis study and hVIVO for influenza challenge study to...
FORT LAUDERDALE, Fla., Sept. 28, 2021 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (NASDAQ: MOTS) ("Motus GI" or the "Company")...
Brings advanced focal ablation to prostate cancer patients in the Pacific Northwest LYON, France, September 28, 2021 -- EDAP TMS...
Research demonstrates that platform technologies generate therapeutic molecules for selective delivery of immune activating signals, such as IL-2, to disease-relevant...
MIAMI, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular...
Supplemental New Drug Application (sNDA) submission is supported by existing clinical data, including positive data from Company’s Phase 3 trial,...
Sydney, AUSTRALIA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a biotechnology...
PHILADELPHIA, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
Preliminary data from prior Phase 1a/2a trial indicated safety of topical formulation of FW-UP and suggested possible favorable efficacy First...
Dr. Rachel Huckfeldt and Dr. Paul Yang to Present 12-Month Findings and Analysis from AGTC’s Clinical TrialsGAINESVILLE, Fla. and CAMBRIDGE, Mass.,...